Molecular imaging in atherosclerosis: FDG PET

Current Atherosclerosis Reports

Volumn 14, Issue 5, 2012, Pages 429-437

  Rosenbaum, David ^a,b   Millon, Antoine ^c   Fayad, Zahi A ^c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

18f fluorodesoxyglucose; Atherosclerotic plaque; Inflammation; Macrophages; Noninvasive imaging; Positron emission tomography

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CATHEPSIN K; CD68 ANTIGEN; DALCETRAPIB; FATTY ACID BINDING PROTEIN; FLUORODEOXYGLUCOSE F 18; GELATINASE B; GLIMEPIRIDE; GLUCOSE TRANSPORTER 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PIOGLITAZONE; PLACEBO; PLATELET DERIVED GROWTH FACTOR; VERAPAMIL;

AGING; ANGIOCARDIOGRAPHY; ANTIINFLAMMATORY ACTIVITY; AORTA ANEURYSM; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG MONITORING; DYSLIPIDEMIA; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC CARDIOMYOPATHY; METABOLIC SYNDROME X; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; STABLE ANGINA PECTORIS;

ANIMALS; ATHEROSCLEROSIS; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84870515691     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-012-0264-x     Document Type: Article

References (50)

1. Ogawa M, Nakamura S, Saito Y, Kosugi M, Magata Y. What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro. Society of Nuclear Medicine official publication. J Nucl Med. 2012;53:55-8.
2. Folco EJ, Sheikine Y, Rocha VZ, et al. Hypoxia but not inflammation augments glucose uptake in human macrophages. Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol. 2011;58:603-14.
3. Derlin T, Habermann CR, Lengyel Z, et al. Feasibility of 11Cacetate PET/CT for imaging of fatty acid synthesis in the atherosclerotic vessel wall. J Nucl Med. 2011;52:1848-54.
4. Worthley SG, Zhang ZY, Machac J, et al. In vivo noninvasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging. 2009;25:251-7.
5. Zhao QM, Feng TT, Zhao X, et al. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Chin Med J. 2011;124:911-7.
6. Vucic E, Dickson SD, Calcagno C, et al. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging. 2011;4:1100-9.
7. Patel R, Janoudi A, Vedre A, et al. Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography. Arterioscler Thromb Vasc Biol. 2011;31:2007-14.
8. Nahrendorf M, Keliher E, Marinelli B, et al. Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography. Arterioscler Thromb Vasc Biol. 2011;31:750-7.
9. Gaeta C, Fernandez Y, Pavia J, et al. Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection. Eur J Nucl Med Mol Imaging. 2011;38:2018-24.
10. Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation. Atherosclerosis. 2007;192(2):275-82.
11. Yoo HJ, Kim S, Park MS, et al. Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET. J Nucl Med. 2011;52:10-7.
12. Pedersen SF, Graebe M, Fisker Hag AM, Hojgaard L, Sillesen H, Kjaer A. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun. 2010;31:423-9.
13. Yang SJ, Kim S, Choi HY, et al. High-sensitivity C-reactive protein in the low- and intermediate-Framingham risk score groups: analysis with (18)F-fluorodeoxyglucose positron emission tomography. Int J Cardiol. 2011. doi:10.1016/j.ijcard.2011.06.054.
14. Myers KS, Rudd JH, Hailman EP, et al. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. JACC Cardiovasc Imaging. 2012;5:38-45.
15. Choi HY, Kim S, Yang SJ, et al. Association of adiponectin, resistin, and vascular inflammation: analysis with 18Ffluorodeoxyglucose positron emission tomography. Arterioscler. Thromb Vasc Biol. 2011;31:944-9.
16. Yoo HJ, Kim S, Park MS, et al. Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab. 2011;96:E488-92.
17. Tahara N, Yamagishi S, Tahara A, et al. Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans. Atherosclerosis. 2011;219:311-5.
18. Pedersen SF, Graebe M, Hag AM, Hoejgaard L, Sillesen H, Kjaer A. Microvessel density but not neoangiogenesis is associated with (18)F-FDG uptake in human atherosclerotic carotid plaques. Mol Imaging Biol. 2012;14(3):384-92.
19. Choi YS, Youn HJ, Chung WB, et al. Uptake of F-18 FDG and ultrasound analysis of carotid plaque. J Nucl Cardiol. 2011;18: 267-72.
20. Graebe M, Pedersen SF, Hojgaard L, Kjaer A, Sillesen H. 18FDG PET and ultrasound echolucency in carotid artery plaques. JACC Cardiovasc Imaging. 2010;3:289-95.
21. Menezes LJ, Kotze CW, Agu O, et al. Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation. J Nucl Med. 2011;52:1698-703.
22. Figueroa AL, Subramanian SS, Cury RC, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging. 2012;5:69-77.
23. Bucerius J, Duivenvoorden R, Mani V, et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011;4:1195-205.
24. Grandpierre S, Desandes E, Meneroux B, et al. Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case-control pilot study. Clin Nucl Med. 2011;36:85-90.
25. Moustafa RR, Izquierdo-Garcia D, Fryer TD, et al. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke: a pilot study. Circ Cardiovasc Imaging. 2010;3:536-41.
26. Kwee RM, Truijman MT, Mess WH, et al. Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques. AJNR Am J Neuroradiol. 2011;32:950-4.
27. Masteling MG, Zeebregts CJ, Tio RA, et al. High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability. J Nucl Cardiol. 2011;18:1066-75.
28. Marnane M, Merwick A, Sheehan OC, et al. Carotid plaque inflammation on (18) F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71 (5)709-18.
29. Muntendam P, McCall C, Sanz J, Falk E, Fuster V. High-risk plaque I. The BioImage study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease-study design and objectives. Am Heart J. 2010;160:49-57e1.
30. Camici PG, Rimoldi OE, Gaemperli O, Libby P. Noninvasive anatomic and functional imaging of vascular inflammation and unstable plaque. Eur Heart J. 2012;33(11):1309-17.
31. Rogers IS, Tawakol A. Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles. Curr Cardiol Rep. 2011; 13:138-44.
32. Saam T, Rominger A, Wolpers S, et al. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. Eur J Nucl Med Mol Imaging. 2010;37:1203-12.
33. Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging. 2010;3:388-97.
34. Balink H, Hut E, Pol T, Flokstra FJ, Roef M. Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydraterestricted diet. J Nucl Med Technol. 2011;39:185-9.
35. Hucker WJ, Jaffer FA. F-FDG PET imaging of atherosclerosis - a new approach to detect inflamed, high-risk coronary plaques? Curr Cardiovasc Imaging Rep. 2011;4:1-3.
36. Schuster A, Morton G, Chiribiri A, Perera D, Vanoverschelde JL, Nagel E. Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance. J Am Coll Cardiol. 2012; 59:359-70.
37. D'Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging. 2009;2:1060-8.
38. Lee WW, Marinelli B, van der Laan AM, et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol. 2012; 59:153-63.
39. Meirelles GS, Gonen M, Strauss HW. 18F-FDG uptake and calcifications in the thoracic aorta on positron emission tomography/computed tomography examinations: frequency and stability on serial scans. J Thorac Imaging. 2011;26:54-62.
40. Xu XY, Borghi A, Nchimi A, et al. High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur J Vasc Endovasc Surg. 2010;39:295-301.
41. Reeps C, Pelisek J, Bundschuh RA, et al. Imaging of acute and chronic aortic dissection by 18F-FDG PET/CT. J Nucl Med. 2010;51:686-91.
42. Kato K, Nishio A, Kato N, Usami H, Fujimaki T, Murohara T. Uptake of 18F-FDG in acute aortic dissection: a determinant of unfavorable outcome. J Nucl Med. 2010;51:674-81.
43. Kotze CW, Groves AM, Menezes LJ, et al. What is the relationship between (1)F-FDG aortic aneurysm uptake on PET/CT and future growth rate? Eur J Nucl Med Mol Imaging. 2011;38:1493-9.
44. Palombo D, Lucertini G, Pane B, Spinella G. Screening for abdominal aortic aneurysm. Questions and results. Acta Chirurgica Belgica. 2011;111:7-11.
45. Marini C, Morbelli S, Armonino R, et al. Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study. Eur J Nucl Med Mol Imaging. 2012;39:91-101.
46. Mizoguchi M, Tahara N, Tahara A, et al. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging. 2011;4:1110-8.
47. Ishii H, Nishio M, Takahashi H, et al. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Clin Therapeut. 2010;32:2337-47.
48. Fayad ZA, Mani V, Woodward M, et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel noninvasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011;378:1547-59.
49. Fifer KM, Qadir S, Subramanian S, et al. Positron emission tomography measurement of periodontal (18)f-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation. J Am Coll Cardiol. 2011;57:971-6.
50. Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CT in Takayasu Arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5:422-9.